Janus Henderson Group’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-304,556
| Closed | -$5.67M | – | 2550 |
|
|
2023
Q3 | $5.67M | Sell |
304,556
-68,387
| -18% | -$1.27M | ﹤0.01% | 787 |
|
|
2023
Q2 | $9.69M | Sell |
372,943
-309,181
| -45% | -$8.03M | 0.01% | 697 |
|
|
2023
Q1 | $19.6M | Buy |
682,124
+68,418
| +11% | +$1.96M | 0.01% | 584 |
|
|
2022
Q4 | $18.2M | Sell |
613,706
-616,688
| -50% | -$18.3M | 0.01% | 589 |
|
|
2022
Q3 | $29.3M | Buy |
1,230,394
+545,633
| +80% | +$13M | 0.01% | 609 |
|
|
2022
Q2 | $15.3M | Sell |
684,761
-5
| -0% | -$112 | 0.01% | 612 |
|
|
2022
Q1 | $17.2M | Buy |
684,766
+112,871
| +20% | +$2.83M | 0.01% | 781 |
|
|
2021
Q4 | $20.5M | Buy |
571,895
+108,110
| +23% | +$3.87M | 0.01% | 781 |
|
|
2021
Q3 | $19.7M | Buy |
463,785
+259,147
| +127% | +$11M | 0.01% | 800 |
|
|
2021
Q2 | $8.86M | Buy |
+204,638
| New | +$8.86M | ﹤0.01% | 949 |
|
|
2019
Q1 | – | Sell |
-7,858
| Closed | -$264K | – | 1345 |
|
|
2018
Q4 | $264K | Buy |
7,858
+168
| +2% | +$5.64K | ﹤0.01% | 1286 |
|
|
2018
Q3 | $324K | Buy |
+7,690
| New | +$324K | ﹤0.01% | 1371 |
|